Clinical Trials - ARMP

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT05616221Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa InfectionCOMPLETEDPHASE22023-01-102024-08-082024-07-17
NCT05184764Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus BacteremiaCOMPLETEDPHASE1, PHASE22022-04-262025-01-142024-11-07
NCT04596319Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic FibrosisCOMPLETEDPHASE1, PHASE22020-12-222022-12-142022-12-14
NCT03196219A Phase 2 Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Varnish and Strip in Adolescent and Adult SubjectsCOMPLETEDPHASE22017-07-072018-01-102017-11-22
NCT03052842A Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Dental Strip ApplicationCOMPLETEDPHASE22017-02-092017-04-052017-04-05
NCT03004365A Study to Evaluate the Safety and Microbiology of C16G2 Varnish Administered in Multiple Doses to Dental SubjectsCOMPLETEDPHASE22017-01-272017-03-292017-03-29
NCT02757755Ascending Dose Study of the Safety of AB-SA01 When Topically Applied to Intact Skin of Healthy AdultsCOMPLETEDPHASE12016-052016-082016-08
NCT02594254Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental SubjectsCOMPLETEDPHASE22015-112016-092016-06
NCT02509845Study to Evaluate the Safety and Microbiology of C16G2 in Adolescent and Adult Dental SubjectsCOMPLETEDPHASE22015-072016-032016-02
NCT02254993Phase 2, Open-Label Study for Safety, Microbiology and PK of Single or Multiple Oral C16G2 Gel DosesCOMPLETEDPHASE22014-102015-072015-06
NCT02044081Phase 2, Safety & Microbiology Study of C16G2 in Multiple Oral Gel &/or Mouth Rinse Doses to Healthy AdultsCOMPLETEDPHASE22014-022014-082014-07